|
XB-GENEPAGE-5810263
Papers associated with tpx2
???pagination.result.count???
???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4
| Sort Newest To Oldest | Sort Oldest To Newest |
TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma., Koike Y, Yin C, Sato Y, Nagano Y, Yamamoto A, Kitajima T, Shimura T, Kawamura M, Matsushita K, Okugawa Y, Amano K, Otake K, Okita Y, Ohi M, Inoue M, Uchida K, Hirayama M, Toiyama Y., Oncol Lett. April 1, 2022; 23 (4): 136. |
|
Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells., Sun B, Long Y, Xiao L, Wang J, Yi Q, Tong D, Li K., J Oncol. April 11, 2022; 2022 6085948. |
|
TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway., Zhu D, Xu X, Zhang M, Wang T., Oncol Lett. May 1, 2022; 23 (5): 143. |
|
LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis., Liu J, Jiang M, Guan J, Wang Y, Yu W, Hu Y, Zhang X, Yang J., J Thorac Dis. October 1, 2022; 14 (10): 4081-4095. |
|
The translation regulator Zar1l controls timing of meiosis in Xenopus oocytes., Heim A, Niedermeier ML, Stengel F, Mayer TU., Development. November 1, 2022; 149 (21):  |
|
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel., Hu J, He Q, Tian T, Chang N, Qian L., Onco Targets Ther. January 1, 2023; 16 197-210. |
|
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs., Wang H, Chu F, Zhang XF, Zhang P, Li LX, Zhuang YL, Niu XF, He X, Li ZJ, Bai Y, Mao D, Liu ZW, Zhang DL, Li BA., Cell Death Dis. January 27, 2023; 14 (1): 64. |
|
Augmin is a Ran-regulated spindle assembly factor., Kraus J, Travis SM, King MR, Petry S., J Biol Chem. June 1, 2023; 299 (6): 104736.  |
|
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer., Guenther M, Surendran SA, Haas M, Heinemann V, von Bergwelt-Baildon M, Engel J, Werner J, Boeck S, Ormanns S., Br J Cancer. July 1, 2023; 129 (1): 175-182.  |
|
[miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma]., Xu J., Zhongguo Fei Ai Za Zhi. October 20, 2023; 26 (10): 721-731. |
|
Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors., Zhu M, Wang X, Zhang Q, Xie C, Wang T, Shen K, Zhang L, Zhou X., Aging (Albany NY). February 2, 2024; 16 (3): 2563-2590. |
???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4